Trial · NCT03284957
Participant flow48
How many started, completed or left each group, period by period.
1 to 20 of 48
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Part A: Amcenestrant 20 mg | 3 | |
| Overall Study | STARTED | Part A: Amcenestrant 150 mg | 3 | |
| Overall Study | STARTED | Part A: Amcenestrant 200 mg | 4 | |
| Overall Study | STARTED | Part A: Amcenestrant 400 mg | 3 | |
| Overall Study | STARTED | Part A: Amcenestrant 600 mg | 3 | |
| Overall Study | STARTED | Part A: Amcenestrant 300 mg BID | 6 | |
| Overall Study | STARTED | Part B: Amcenestrant 400 mg | 49 | |
| Overall Study | STARTED | Part C: Amcenestrant 200 mg + Palbociclib 125 mg | 9 | |
| Overall Study | STARTED | Part C: Amcenestrant 400 mg + Palbociclib 125 mg | 6 | |
| Overall Study | STARTED | Part D: Amcenestrant 200 mg + Palbociclib 125 mg | 30 | |
| Overall Study | STARTED | Part F: Amcenestrant 200 mg + Alpelisib 300 mg | 8 | |
| Overall Study | STARTED | Part H: Amcenestrant 200 mg + Everolimus 5 mg | 3 | |
| Overall Study | STARTED | Part H: Amcenestrant 200 mg + Everolimus 10 mg | 3 | |
| Overall Study | STARTED | Part I: Amcenestrant 200 mg + Everolimus 10 mg | 1 | |
| Overall Study | STARTED | Part J: Amcenestrant 200 mg + Abemaciclib 100 mg BID | 3 | |
| Overall Study | STARTED | Part J: Amcenestrant 200 mg + Abemaciclib 150 mg BID | 2 | |
| Overall Study | COMPLETED | Part A: Amcenestrant 20 mg | 0 | |
| Overall Study | COMPLETED | Part A: Amcenestrant 150 mg | 0 | |
| Overall Study | COMPLETED | Part A: Amcenestrant 200 mg | 0 | |
| Overall Study | COMPLETED | Part A: Amcenestrant 400 mg | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03284957/flow